Pharma
Should We Start Worrying About Pharmaceutical Patent Trolls?
An expert told us there "a gold rush for profit" in patent-centric areas such as the drug biz.
Treating the Elusive, Disabling ‘Flatness’ of Schizophrenia
A new drug on track for FDA approval offers hope.
'Pink Viagra' Is Coming to Solve a Problem That May Not Exist
The new pill won’t address the majority of women’s issues with sex.
The Perfect Birth Control for Men Is Here. Why Can't We Use It?
After 30 years, the male birth control shot finally has momentum in the US.
Enduring the Aftershock of OxyContin in Canada
Purdue Pharma had successfully engineered a slanted, disingenuous marketing campaign clearly designed to sell more OxyContin, and passed it off as a mandatory educational lecture at a major university. Nearly seven thousand students received this...
How 'Pay-for-Delay' Keeps Brand-Name Drug Prices High While Blocking Generics
The practice is no closed-door secret, and finds brand-name drug manufacturers offering financial incentives--one might call them bribes--to generic manufacturers so as to prevent generic drugs from entering the market.
Oxycontin in Ontario: Wildly Addictive and Barely Regulated
OxyContin is basically a synthetic version of heroin, and as such, is often referred to as ”Hillbilly-heroin.” It was marketed as an effective, time-released painkiller, but its highly addictive nature has created an epidemic of severe long-term...
How Big Pharma Created a Generation of Oxyconteens in the US
Now that Purdue Pharma, the creator of OxyContin, is set to begin testing the effects of OC on children—an effort to procure a six-month patent extension for their drug—I wanted to look back on Big Pharma hooking a generation of Americans on legal...